PMID: 9192685Jun 24, 1997Paper

Glutamine synthetase protects against neuronal degeneration in injured retinal tissue

Proceedings of the National Academy of Sciences of the United States of America
R GorovitsL Vardimon

Abstract

The neurotransmitter glutamate is neurotoxic when it is accumulated in a massive amount in the extracellular fluid. Excessive release of glutamate has been shown to be a major cause of neuronal degeneration after central nervous system injury. Under normal conditions, accumulation of synaptically released glutamate is prevented, at least in part, by a glial uptake system in which the glia-specific enzyme glutamine synthetase (GS) plays a key role. We postulated that glial cells cannot cope with glutamate neurotoxicity because the level of GS is not high enough to catalyze the excessive amounts of glutamate released by damaged neurons. We examined whether elevation of GS expression in glial cells protects against neuronal degeneration in injured retinal tissue. Analysis of lactate dehydrogenase efflux, DNA fragmentation, and histological sections revealed that hormonal induction of the endogenous GS gene in retinal glial cells correlates with a decline in neuronal degeneration, whereas inhibition of GS activity by methionine sulfoximine leads to increased cell death. A supply of purified GS enzyme to the culture medium of retinal explants or directly to the embryo in ovo causes a dose-dependent decline in the extent of cell deat...Continue Reading

References

Dec 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·P Linser, A A Moscona
Jan 13, 1992·Brain Research·C K PetitoA J Cooper
Jul 1, 1992·Journal of Neurochemistry·P Louzada-JúniorJ Coutinho-Netto
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·D Gunnersen, B Haley
Jun 1, 1992·Archives of Ophthalmology·M RosnerM O Tso
Aug 1, 1991·Experimental Cell Research·B BrüneS Orrenius
Aug 30, 1991·Biochemical and Biophysical Research Communications·S KureK Narisawa
Jan 1, 1990·Annual Review of Neuroscience·D W Choi, S M Rothman
Feb 1, 1986·Annals of Neurology·S M Rothman, J W Olney
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L VardimonA A Moscona
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·L VardimonA A Moscona
Nov 1, 1974·Nature·A J KennedyJ Marshall
Sep 1, 1994·Molecular Endocrinology·S Reisfeld, L Vardimon
Mar 1, 1994·Journal of Neurochemistry·M J NealJ Hogg
Feb 1, 1994·Brain Research. Molecular Brain Research·R GrossmanL Vardimon
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·R GorovitsL Vardimon
Feb 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·I Ben-DrorL Vardimon
Dec 24, 1993·Neuroscience Letters·J P MacManusE Preston
Dec 1, 1993·Stroke; a Journal of Cerebral Circulation·M D LinnikM D Hatfield
Dec 31, 1996·Brain Research. Molecular Brain Research·R GorovitsL Vardimon
Sep 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·A A MosconaN Saenz

❮ Previous
Next ❯

Citations

May 23, 2000·The Anatomical Record·M M Jablonski, C S Ervin
Jan 29, 2002·Journal of Neuroscience Research·Amira WohabrebbiMonica M Jablonski
Mar 29, 2006·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Peter Heiduschka, Solon Thanos
Jun 16, 2005·Toxicology·Lidia StruzyńskaGrzegorz Sulkowski
Jul 23, 1999·Survey of Ophthalmology·N N OsborneM S Nash
May 22, 2002·Neurochemistry International·I SuárezB Fernández
Oct 30, 2007·Nature Neuroscience·David J RossiClaudia Mohr
Apr 23, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Eun-Sook Y LeeMichael Aschner
Aug 3, 2002·Journal of Neurochemistry·Barbara AhlemeyerJosef Krieglstein
Oct 23, 2002·Journal of Neurochemistry·Iftach ShakedLily Vardimon
Jun 27, 2015·Progress in Retinal and Eye Research·Elena VecinoSansar C Sharma
Jun 9, 2004·Glia·Elizabeth WoldemussieGuadalupe Ruiz
Jan 30, 2014·Annals of Occupational and Environmental Medicine·Pratap KarkiMichael Aschner
Jun 20, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Akiko HosokiTsunehiko Ikeda
May 15, 2015·Annual Review of Nutrition·Kyle J HorningMichael Aschner
Apr 29, 2014·Frontiers in Endocrinology·Leif Hertz, Tiago B Rodrigues
Aug 13, 2014·Neurochemical Research·Alexei VerkhratskyLeif Hertz
Jun 22, 2016·Experimental Eye Research·Adam M HanifMachelle T Pardue
Jul 15, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·V Sánchez-VallejoM Miranda
Dec 19, 2003·Annals of Neurology·Masayuki FujiokaBo K Siesjö

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.